BE903029A - Nouvelles formes pharmaceutiques administrables par voie nasale. - Google Patents

Nouvelles formes pharmaceutiques administrables par voie nasale.

Info

Publication number
BE903029A
BE903029A BE1/011312A BE1011312A BE903029A BE 903029 A BE903029 A BE 903029A BE 1/011312 A BE1/011312 A BE 1/011312A BE 1011312 A BE1011312 A BE 1011312A BE 903029 A BE903029 A BE 903029A
Authority
BE
Belgium
Prior art keywords
nasal
pharmaceutical forms
new pharmaceutical
administrable
forms administrable
Prior art date
Application number
BE1/011312A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE903029A publication Critical patent/BE903029A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L2101/00—Uses or applications of pigs or moles
    • F16L2101/10—Treating the inside of pipes
    • F16L2101/12—Cleaning

Abstract

Composition pharmaceutique pour l'administration systémique par voie nasale et comprenant, comme substance active, un antagoniste du calcium choisi parmi les 1,4-dihydropyridines éventuellement substituées comportant en position 4 un groupe monocyclique, en association avec un véhicule non toxique pharmaceutiquement acceptable et approprié pour l'administration par voie nasale.
BE1/011312A 1984-08-10 1985-08-08 Nouvelles formes pharmaceutiques administrables par voie nasale. BE903029A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8412668A FR2568773B1 (fr) 1984-08-10 1984-08-10 Nouvelles compositions pharmaceutiques administrables par voie nasale

Publications (1)

Publication Number Publication Date
BE903029A true BE903029A (fr) 1986-02-10

Family

ID=9306963

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011312A BE903029A (fr) 1984-08-10 1985-08-08 Nouvelles formes pharmaceutiques administrables par voie nasale.

Country Status (10)

Country Link
US (1) US4885305A (fr)
JP (1) JPS6147415A (fr)
AT (1) AT388670B (fr)
BE (1) BE903029A (fr)
CH (1) CH668186A5 (fr)
DE (1) DE3527587A1 (fr)
FR (1) FR2568773B1 (fr)
GB (2) GB2162745B (fr)
IL (1) IL76042A0 (fr)
IT (1) IT1200099B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
ES2038696T3 (es) * 1986-03-10 1996-07-16 Burghart Kurt Procedimiento para producir un preparado farmaceutico.
EP0302595B1 (fr) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil pour le traitement de l'hypertension pulmonaire ou de l'insuffisance ventriculaire droite
US4950664A (en) * 1988-09-16 1990-08-21 Rugby-Darby Group Companies, Inc. Nasal administration of benzodiazepine hypnotics
USRE36744E (en) * 1988-09-16 2000-06-20 Ribogene, Inc. Nasal administration of benzodiazepine hypnotics
CA2011063C (fr) * 1989-02-28 1999-07-06 Calum B. Macfarlane Compose pharmaceutique de nicardipine pour administration parenterale
GB8926715D0 (en) * 1989-11-28 1990-01-17 Haessle Ab Improvements relating to the administration of pharmaceutical agents
CA2417727C (fr) * 2000-07-31 2009-09-01 Nycomed Danmark A/S Composition a base de fentanyl destinee a l'administration nasale
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
EP1933837A4 (fr) * 2005-10-14 2009-07-15 Transform Pharmaceuticals Inc Compositions pharmaceutiques liquides de nimodipine
US8337906B2 (en) * 2006-07-25 2012-12-25 Zinreich James Nasal composition
US20080026078A1 (en) * 2006-07-25 2008-01-31 Zinreich James Nasal composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3209276A1 (de) * 1982-03-13 1983-09-15 Bayer Ag, 5090 Leverkusen Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung
JPS59152320A (ja) * 1983-02-17 1984-08-31 Takeda Chem Ind Ltd 水性製剤
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
US4686217A (en) * 1983-04-27 1987-08-11 Fisons Plc Calcium antagonist 2-fluoroalkyl-1,4-dihydropyridines
US4607041A (en) * 1983-04-27 1986-08-19 Fisons Plc Antihypertensive 2-phenyl Hantzsch dihydropyridines
DE3326089A1 (de) * 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
US4525341A (en) * 1984-04-09 1985-06-25 Mayor Pharmaceutical Laboratories, Inc. Method of administering vitamins

Also Published As

Publication number Publication date
AT388670B (de) 1989-08-10
US4885305A (en) 1989-12-05
DE3527587A1 (de) 1986-02-20
IT8548428A0 (it) 1985-07-31
FR2568773B1 (fr) 1989-03-03
FR2568773A1 (fr) 1986-02-14
ATA233485A (de) 1989-01-15
GB8810747D0 (en) 1988-06-08
CH668186A5 (de) 1988-12-15
GB2162745B (en) 1989-05-17
GB2203044B (en) 1989-06-01
GB8519847D0 (en) 1985-09-11
IL76042A0 (en) 1985-12-31
IT1200099B (it) 1989-01-05
JPS6147415A (ja) 1986-03-07
GB2203044A (en) 1988-10-12
GB2162745A (en) 1986-02-12

Similar Documents

Publication Publication Date Title
FR2678169B1 (fr) Nouvelles compositions pharmaceutiques comprenant une cyclosporine, pour l'administration par voie orale.
IT1201087B (it) Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
BE903029A (fr) Nouvelles formes pharmaceutiques administrables par voie nasale.
LU91037I2 (fr) Somatulina autogel
BE849632A (fr) Composition pharmaceutique pour l'administration orale
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
MY100359A (en) External pharmaceutical composition.
FR2673538B1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
FR2547503B1 (fr) Nouveau systeme solvant-auxiliaire de penetration pour l'administration d'agents physiologiquement actifs par administration percutanee
IE802033L (en) Dibenzazepine derivatives
IT8222566A0 (it) Derivato dell'acido ursolico farmacologicamente attivo.
FR2622446B1 (fr) Agent pour reduire la nephrotoxicite produite par l'administration de cyclosporine
ES8403458A1 (es) "un procedimiento para la preparacion de nuevos derivados de tetrahidroquinolina".
IE37288L (en) Crane assembly
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
EP0396169A3 (fr) Composition pharmaceutique pour utilisation topique ophtalmique ayant une tolérance locale modifiée
FR2691630B1 (fr) Composition pharmaceutique, en particulier pour l'administration orale, contenant, comme ingrédient actif, un agoniste sélectif des récepteurs de type 5HT1.
IE43848L (en) Pharmaceutical compositions
IT7921832A0 (it) Farmacologicamente attivi. esteri dell'acido n-(3-trifluorometilfenil)antranilico, procedimento per laloro preparazione e loro preparati
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
IT8719564A0 (it) Piperazine asimmetriche adattivita' farmacologica, procedimento per la loro preparazione e compisizioni farmaceutiche relative.
IT8224856A0 (it) Piperazine asimmetriche adattivita' farmacologica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
IT8422633A0 (it) Aril-alchil-piperazine farmaceuticamente attive, procedimenti per la loro preparazione e composizioni relative.
IE41053B1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: YAMANOUCHI PHARMACEUTICAL

Effective date: 19920831